You searched for supplemental oxygen

News

Dapagliflozin Does Not Improve Kidney Outcomes in Hospitalized COVID-19 Cases

May 10, 2022

Investigators report findings from a secondary analysis of the DARE-19 trial, which compared dapagliflozin with placebo in patients hospitalized with COVID-19.

News

Tocilizumab Shortage Prompts Temporary REMS Change for CAR T-Cell Therapy

December 14, 2021

Shortly after an EUA was issued, Genentech announced that tocilizumab (marketed under the brand name Actemra) was in shortage.

News

Convalescent Plasma Not Efficacious in Hospitalized COVID-19 Patients

December 14, 2021

No significant difference versus placebo observed for hospitalized patients with COVID-19 receiving noninvasive supplemental oxygen

News

FDA Authorizes Emergency Use of Actemra for COVID-19

June 28, 2021

The EUA was issued based on 4 randomized controlled clinical trials that evaluated the efficacy and safety of Actemra in more than 5500 hospitalized patients with COVID-19.

Drugs in the Pipeline

Mixed Results for Baricitinib in Trial of Hospitalized COVID-19 Patients

April 8, 2021

Findings showed that the trial did not meet statistical significance on the primary endpoint.

News

Small Study Tests Colchicine for Moderate-to-Severe COVID-19

February 8, 2021

Authors call for larger clinical trials to further evaluate the efficacy and safety of colchicine as an adjunctive therapy for COVID-19

News

Tocilizumab Does Not Prevent Intubation, Death in COVID-19

October 23, 2020

Intubation or death, disease worsening similar for tocilizumab, placebo in hospitalized patients.

News

Steroid May Reduce COVID-19 Death Risk by Up to One-Third

June 17, 2020

Dexamethasone appears promising for patients with severe illness.

News

Five-Day Course of Remdesivir Beneficial in Severe COVID-19

June 1, 2020

No significant difference seen in five-, 10-day course for severe COVID-19 without mechanical ventilation.

News

Lopinavir-Ritonavir Does Not Offer Substantial Benefit in Severe COVID-19

March 20, 2020

In patients who were hospitalized with severe coronavirus disease, treatment with lopinavir-ritonavir did not provide a substantial benefit beyond standard care.

Active Filters

Your search for supplemental oxygen returned 20 results

Sort Results:

Dapagliflozin Does Not Improve Kidney Outcomes in Hospitalized COVID-19 Cases

Tocilizumab Shortage Prompts Temporary REMS Change for CAR T-Cell Therapy

Convalescent Plasma Not Efficacious in Hospitalized COVID-19 Patients

FDA Authorizes Emergency Use of Actemra for COVID-19

Mixed Results for Baricitinib in Trial of Hospitalized COVID-19 Patients

Small Study Tests Colchicine for Moderate-to-Severe COVID-19

Tocilizumab Does Not Prevent Intubation, Death in COVID-19

Steroid May Reduce COVID-19 Death Risk by Up to One-Third

Five-Day Course of Remdesivir Beneficial in Severe COVID-19

Lopinavir-Ritonavir Does Not Offer Substantial Benefit in Severe COVID-19